TY  - GEN
AU  - DiPaola,Robert S
AU  - Chen,Yu-Hui
AU  - Stein,Mark
AU  - Vaughn,David
AU  - Patrick-Miller,Linda
AU  - Carducci,Michael
AU  - Roth,Bruce
AU  - White,Eileen
AU  - Wilding,George
TI  - A randomized phase II trial of mitoxantrone, estramustine and vinorelbine or bcl-2 modulation with 13-cis retinoic acid, interferon and paclitaxel in patients with metastatic castrate-resistant prostate cancer: ECOG 3899
SN  - 1479-5876
PY  - 2010///0707
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Agents
KW  - therapeutic use
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Estramustine
KW  - Humans
KW  - Interferons
KW  - Isotretinoin
KW  - Male
KW  - Middle Aged
KW  - Mitoxantrone
KW  - Neoplasm Metastasis
KW  - Paclitaxel
KW  - Prostatic Neoplasms
KW  - drug therapy
KW  - Proto-Oncogene Proteins c-bcl-2
KW  - metabolism
KW  - Quality of Life
KW  - Survival Rate
KW  - Teratogens
KW  - Treatment Outcome
KW  - Vinblastine
KW  - analogs & derivatives
KW  - Vinorelbine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.1186/1479-5876-8-20
ER  -